7 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 7 of 7 clinical reviews.
Is compounding ezetimibe (Zetia) legal? Full regulatory breakdown covering FDA approval history, compounding restrictions under 503A/503B, the current label, and safety data from IMPROVE-IT.
A complete regulatory timeline of ezetimibe (Zetia) from its 2002 FDA approval through IMPROVE-IT outcomes data, generic entry, and current labeling.
Complete regulatory overview of ezetimibe (Zetia) worldwide, covering FDA approval history, EMA authorization, label updates, IMPROVE-IT trial impact, generic availability, and ongoing post-market surveillance.
A review of ezetimibe's regulatory timeline, patent litigation, the ENHANCE controversy, the IMPROVE-IT outcomes trial, and how those disputes relate to today's generic ezetimibe.
A detailed comparison of how the FDA and EMA have regulated ezetimibe (Zetia/Ezetrol), from initial approval through post-market surveillance, label updates, and the IMPROVE-IT outcomes data.
A complete breakdown of every Zetia (ezetimibe) FDA label update from 2020 through 2026, including safety signal changes, new indication data, and what prescribers and patients need to know.
A clinical review of ezetimibe (Zetia) regulatory history, FDA approval timeline, current label details, post-market safety surveillance, and next-generation lipid-lowering pipeline candidates.